However, on July 23-24, 2026, the FDAs Pharmacy Compounding Advisory Committee (PCAC) voted on inclusion of three of KLOWs peptide compounds for the 503A Bulks List: BPC-157 : 8-6 voted in favor of inclusion, with one abstention TB-500 : 8-6 voted in favor of inclusion, with one abstention KPV : 8-6 voted in favor of inclusion, with one abstention Note: TB-500 is a fragment of the full-length thymosin beta-4 (43 amino acids)
9A) revealed dominant branching within Bacillota phylum and expansion of inflammation-associated taxa such as Peptostreptococcales-Tissierellales, Monoglobaceae, and Christensenellaceae in the VPA-ASD group, accompanied by markedly reduced representation of Bacteroidota
doi: 10.1111/dom.14503 162 BesshoRTakiyamaYTakiyamaTKitsunaiHTakedaYSakagamiHet al
We have shown that effective pharmacologic inhibition of GPX4 in PTC cells with direct inhibitor RSL3 induces a robust activation of ferroptosis, increased DNA damage, impaired DNA damage repair response due to reduced p-NPM1 levels, decreased cell viability and cell migration, as well as suppressed spheroid formation and viability in vitro
Fine for larger doses, but problematic if you need 100 mcg, because 100 mcg would be just 0.02 mL, or 2 units on the syringe
97% Clearance
